scholarly article | Q13442814 |
P2093 | author name string | Wright JW | |
Harding JW | |||
Pederson ES | |||
Hanesworth JM | |||
Kramár EA | |||
Stubley L | |||
P2860 | cites work | Place cells and place navigation | Q24683996 |
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 | Q28282369 | ||
Place navigation impaired in rats with hippocampal lesions | Q29547869 | ||
Developments of a water-maze procedure for studying spatial learning in the rat | Q29617561 | ||
Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow | Q32036552 | ||
Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus | Q34189802 | ||
Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat. | Q34279626 | ||
The hippocampus and space revisited | Q34524954 | ||
Brain and Pituitary Angiotensin | Q36266635 | ||
Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist | Q36837133 | ||
Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes | Q36854986 | ||
Biochemistry and pharmacology of the renin-angiotensin system | Q38145882 | ||
The hippocampal formation is necessary for rats to learn and remember configural discriminations | Q39368062 | ||
Cholinergic Neural Regulation of Regional Cerebral Blood Flow | Q40441423 | ||
The angiotensin IV system: functional implications | Q40537981 | ||
Impaired brain microcirculation may trigger Alzheimer's disease | Q40645732 | ||
On the role of the hippocampus in learning and memory in the rat. | Q40769470 | ||
Long-term potentiation and N-methyl-D-aspartate receptors: foundations of memory and neurologic disease? | Q41018287 | ||
Hippocampal connections and spatial discrimination | Q41038114 | ||
The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro | Q41089018 | ||
Long-term enhancement of hippocampal synaptic transmission and the acquisition of spatial information | Q41364651 | ||
Neuronal properties of clonal hybrid cell lines derived from central cholinergic neurons | Q42525923 | ||
Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor | Q44413571 | ||
Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. | Q46039406 | ||
Angiotensin, thirst, and sodium appetite | Q47802019 | ||
Mapping of angiotensin AT1 receptors in the rat limbic system | Q48311548 | ||
Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory | Q48381985 | ||
Pressor action and dipsogenicity induced by angiotensin II and III in rats | Q48438752 | ||
Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus. | Q48467453 | ||
Rats with fimbria-fornix lesions are impaired in path integration: a role for the hippocampus in "sense of direction". | Q48487149 | ||
Tracing of the entorhinal-hippocampal pathway in vitro | Q48500020 | ||
Bilateral knife cuts to the perforant path disrupt spatial learning in the Morris water maze | Q48602975 | ||
Amnesia with hippocampal lesions after cardiopulmonary arrest | Q48675332 | ||
Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats | Q48682751 | ||
Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles | Q48710725 | ||
Intracellular injections of EGTA block induction of hippocampal long-term potentiation | Q48724517 | ||
The characterization of an amnesic syndrome following hypoxic ischemic injury | Q48785420 | ||
Proposed update of angiotensin receptor nomenclature | Q48791533 | ||
Origin and termination of the hippocampal perforant path in the rat studied by silver impregnation | Q48801345 | ||
Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats | Q48934009 | ||
Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats | Q48986724 | ||
Distribution of AT4 receptors in the Macaca fascicularis brain | Q49055335 | ||
Hippocampus, amygdala, and memory deficits in rats | Q49100759 | ||
Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. | Q51630261 | ||
Morphological changes associated with long-term potentiation. | Q52036890 | ||
Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. | Q52185174 | ||
Ibotenate Lesions of Hippocampus and/or Subiculum: Dissociating Components of Allocentric Spatial Learning. | Q52242628 | ||
Hippocampal granule cells are necessary for normal spatial learning but not for spatially-selective pyramidal cell discharge. | Q52247987 | ||
Hippocampal, granule cell and CA3-4 lesions impair formation of a place learning-set in the rat and induce reflex epilepsy. | Q52257059 | ||
Searching for drugs that combat Alzheimer's. | Q53320666 | ||
Effects of angiotensin II and IV on geniculate activity in nontransgenic and transgenic rats | Q56963769 | ||
Regulatory role of brain angiotensins in the control of physiological and behavioral responses | Q67524996 | ||
Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation | Q70813999 | ||
A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat | Q71678874 | ||
Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats | Q71725922 | ||
AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues | Q72120113 | ||
AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides | Q72714925 | ||
Central angiotensin IV binding sites: distribution and specificity in guinea pig brain | Q72922615 | ||
Important role for angiotensin III and IV in the brain renin-angiotensin system | Q73881047 | ||
Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues | Q77362773 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3952-3961 | |
P577 | publication date | 1999-05-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning | |
P478 | volume | 19 |
Q26861984 | A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases |
Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
Q37336892 | Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy |
Q45155033 | Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism. |
Q40075301 | Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro |
Q46370959 | Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease |
Q36923103 | Angiotensin IV upregulates the activity of protein phosphatase 1α in Neura-2A cells |
Q37045324 | Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets |
Q35613025 | Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. |
Q28266068 | Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear |
Q37091405 | Central administration of angiotensin IV rapidly enhances novel object recognition among mice |
Q41474517 | Cognitive enhancing effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on learning and memory |
Q42555106 | Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides. |
Q30235254 | Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review |
Q33393907 | Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase |
Q34543485 | Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. |
Q44745545 | Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension |
Q30530935 | Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents |
Q24635261 | Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs |
Q35210016 | Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers |
Q36415423 | Importance of the brain Angiotensin system in Parkinson's disease |
Q43086630 | Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides |
Q35723480 | Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory |
Q36576477 | Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. |
Q36996248 | Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review |
Q36062244 | Molecular evidence of tissue renin-angiotensin systems: a focus on the brain |
Q61785672 | Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides |
Q55007046 | Targeting Renin-Angiotensin System Against Alzheimer's Disease. |
Q33771966 | The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats |
Q33755200 | The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor |
Q38005611 | The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases |
Q34125016 | The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysin |
Q91864202 | The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics |
Q28247293 | The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system |
Q33915412 | The renin angiotensin system and the metabolic syndrome |
Search more.